| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
- Venetoclax-D8
-
- $322.00
-
2026-07-27
- CAS:1257051-06-1
- Purity: 99.47%
- Supply Ability: 10g
|
| | Venetoclax D8 Basic information |
| Product Name: | Venetoclax D8 | | Synonyms: | Venetoclax D8;Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl-2,2,3,3,5,5,6,6-d8]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;Venetoclax-d8 (piperazine-d8);Venetoclax-d8: 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)benzamide;D8-Venetoclax;Venetoclax-D8 (Standard);VENETOCLAX-D8 | | CAS: | 1257051-06-1 | | MF: | C45H42ClD8N7O7S | | MW: | 876.49 | | EINECS: | | | Product Categories: | | | Mol File: | 1257051-06-1.mol |  |
| | Venetoclax D8 Chemical Properties |
| form | Solid | | color | Light yellow to yellow |
| | Venetoclax D8 Usage And Synthesis |
| Uses | Venetoclax-d8 is deuterium labeled Venetoclax. Venetoclax (ABT-199; GDC-0199) is a highly potent, selective and orally bioavailable Bcl-2 inhibitor with a Ki of less than 0.01 nM. Venetoclax induces autophagy[1][2][3]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. DOI:10.1177/1060028018797110
[2] Souers AJ, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013 Feb;19(2):202-8. DOI:10.1038/nm.3048
[3] Peirs S, et al. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia. Blood. 2014 Dec 11;124(25):3738-47. DOI:10.1182/blood-2014-05-574566
[4] Bi C, et al. Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas. Haematologica. 2017 Apr;102(4):755-764. DOI:10.3324/haematol.2016.159160 |
| | Venetoclax D8 Preparation Products And Raw materials |
|